Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Marson

Showing results (91-100 of 129) with videos related to

Pageof 13
Sort By:
The EMBO Journal|September 1, 2018
CRL4<sup>AMBRA1</sup> targets Elongin C for ubiquitination and degradation to modulate CRL5 signalingSi-Han Chen, Gwendolyn M Jang, Ruth Hüttenhain, et al.
Nature Genetics|October 2, 2019
Landscape of stimulation-responsive chromatin across diverse human immune cellsDiego Calderon, Michelle L T Nguyen, Anja Mezger, et al.
Biorxiv : the Preprint Server for Biology|December 19, 2025
Virus-like particles enable targeted gene engineering and pooled CRISPR screening in primary human myeloid cellsHyuncheol Jung, Pascal Devant, Carter Ching, et al.
Cell|August 12, 2008
Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cellsAlexander Marson, Stuart S Levine, Megan F Cole, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 11, 2025
Gene-corrected regulatory T cell therapy for IL2RA deficiencyAlvin S Ha, Nechama Kalter, Michael Rosenberg, et al.
Mbio|February 27, 2024
CRISPR-Cas9 screen of E3 ubiquitin ligases identifies TRAF2 and UHRF1 as regulators of HIV latency in primary human T cellsUjjwal Rathore, Paige Haas, Vigneshwari Easwar Kumar, et al.
Nature Immunology|September 29, 2020
Functional CRISPR dissection of gene networks controlling human regulatory T cell identityKathrin Schumann, Siddharth S Raju, Michael Lauber, et al.
The Journal of Experimental Medicine|June 16, 2020
Layilin augments integrin activation to promote antitumor immunityKelly M Mahuron, Joshua M Moreau, Jeff E Glasgow, et al.
Cell Reports|April 13, 2022
Global post-translational modification profiling of HIV-1-infected cells reveals mechanisms of host cellular pathway remodelingJeffrey R Johnson, David C Crosby, Judd F Hultquist, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Site-specific genome engineering of primary human natural killer cells for programmable anti-tumor functionVincent Allain, Allison G Rothrock, Pierre-Louis Bernard, et al.
Pageof 13

Showing results (91-100 of 129) with videos related to

Sort By:
Pageof 13
The EMBO Journal|September 1, 2018
CRL4<sup>AMBRA1</sup> targets Elongin C for ubiquitination and degradation to modulate CRL5 signalingSi-Han Chen, Gwendolyn M Jang, Ruth Hüttenhain, et al.
Nature Genetics|October 2, 2019
Landscape of stimulation-responsive chromatin across diverse human immune cellsDiego Calderon, Michelle L T Nguyen, Anja Mezger, et al.
Biorxiv : the Preprint Server for Biology|December 19, 2025
Virus-like particles enable targeted gene engineering and pooled CRISPR screening in primary human myeloid cellsHyuncheol Jung, Pascal Devant, Carter Ching, et al.
Cell|August 12, 2008
Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cellsAlexander Marson, Stuart S Levine, Megan F Cole, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 11, 2025
Gene-corrected regulatory T cell therapy for IL2RA deficiencyAlvin S Ha, Nechama Kalter, Michael Rosenberg, et al.
Mbio|February 27, 2024
CRISPR-Cas9 screen of E3 ubiquitin ligases identifies TRAF2 and UHRF1 as regulators of HIV latency in primary human T cellsUjjwal Rathore, Paige Haas, Vigneshwari Easwar Kumar, et al.
Nature Immunology|September 29, 2020
Functional CRISPR dissection of gene networks controlling human regulatory T cell identityKathrin Schumann, Siddharth S Raju, Michael Lauber, et al.
The Journal of Experimental Medicine|June 16, 2020
Layilin augments integrin activation to promote antitumor immunityKelly M Mahuron, Joshua M Moreau, Jeff E Glasgow, et al.
Cell Reports|April 13, 2022
Global post-translational modification profiling of HIV-1-infected cells reveals mechanisms of host cellular pathway remodelingJeffrey R Johnson, David C Crosby, Judd F Hultquist, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Site-specific genome engineering of primary human natural killer cells for programmable anti-tumor functionVincent Allain, Allison G Rothrock, Pierre-Louis Bernard, et al.
Pageof 13